Figure 3From: Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) Overall surival (A) and progression-free survival (B) according to the modified stage in primary adrenal DLBCL. Back to article page